Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between Continuous and Pulsed Oral Doxycycline Treatment Protocols for Refractory Meibomian Gland Dysfunction - 9 Months Follow-up Prospective Study

NCT06520007 is registered in ClinicalTrials.gov with University of Milan as lead sponsor.

NCT NCT06520007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06520007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between Continuous and Pulsed Oral Doxycycline Treatment Protocols for Refractory Meibomian Gland Dysfunction - 9 Months Follow-up Prospective Study
Lead sponsor
University of Milan
Phase
Observational
Overall status
Completed
Start date
March 1, 2023
Completion date
May 1, 2024
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blepharitis, doxycycline adverse reaction, meibomian gland dysfunction